Logo image of RVTY

REVVITY INC (RVTY) Stock Overview

USA - NYSE:RVTY - US7140461093 - Common Stock

98.89 USD
+1.32 (+1.35%)
Last: 10/24/2025, 8:04:01 PM
99.5 USD
+0.61 (+0.62%)
After Hours: 10/24/2025, 8:04:01 PM

RVTY Key Statistics, Chart & Performance

Key Statistics
Market Cap11.48B
Revenue(TTM)2.80B
Net Income(TTM)285.20M
Shares116.07M
Float115.68M
52 Week High129.5
52 Week Low81.36
Yearly Dividend0.28
Dividend Yield0.3%
EPS(TTM)4.89
PE20.22
Fwd PE18.04
Earnings (Next)10-27 2025-10-27/bmo
IPO1965-07-06
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


RVTY short term performance overview.The bars show the price performance of RVTY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15

RVTY long term performance overview.The bars show the price performance of RVTY in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10

The current stock price of RVTY is 98.89 USD. In the past month the price increased by 17.64%. In the past year, price decreased by -14.99%.

REVVITY INC / RVTY Daily stock chart

RVTY Latest News, Press Relases and Analysis

RVTY Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.56 216.18B
DHR DANAHER CORP 28.92 159.69B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 148.65 48.49B
A AGILENT TECHNOLOGIES INC 27.16 41.97B
IQV IQVIA HOLDINGS INC 19.23 37.49B
MTD METTLER-TOLEDO INTERNATIONAL 35.07 29.55B
WST WEST PHARMACEUTICAL SERVICES 42.07 21.39B
WAT WATERS CORP 29.39 21.40B
MEDP MEDPACE HOLDINGS INC 42.32 17.00B
ILMN ILLUMINA INC 24.06 15.39B
TEM TEMPUS AI INC N/A 15.50B
ICLR ICON PLC 13.5 13.85B

About RVTY

Company Profile

RVTY logo image Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts and currently employs 11,000 full-time employees. The firm has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

Company Info

REVVITY INC

77 4Th Avenue

Waltham MASSACHUSETTS US

Employees: 11000

RVTY Company Website

RVTY Investor Relations

Phone: 17816636900

REVVITY INC / RVTY FAQ

What does RVTY do?

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts and currently employs 11,000 full-time employees. The firm has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.


Can you provide the latest stock price for REVVITY INC?

The current stock price of RVTY is 98.89 USD. The price increased by 1.35% in the last trading session.


What is the dividend status of REVVITY INC?

REVVITY INC (RVTY) has a dividend yield of 0.3%. The yearly dividend amount is currently 0.28.


What is the ChartMill rating of REVVITY INC stock?

RVTY has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


Can you provide the sector and industry classification for REVVITY INC?

REVVITY INC (RVTY) operates in the Health Care sector and the Life Sciences Tools & Services industry.


Is REVVITY INC (RVTY) expected to grow?

The Revenue of REVVITY INC (RVTY) is expected to grow by 3.49% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the market cap for REVVITY INC?

REVVITY INC (RVTY) has a market capitalization of 11.48B USD. This makes RVTY a Large Cap stock.


RVTY Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to RVTY. When comparing the yearly performance of all stocks, RVTY is a bad performer in the overall market: 81.03% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

RVTY Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to RVTY. RVTY has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

RVTY Financial Highlights

Over the last trailing twelve months RVTY reported a non-GAAP Earnings per Share(EPS) of 4.89. The EPS increased by 5.62% compared to the year before.


Industry RankSector Rank
PM (TTM) 10.19%
ROA 2.31%
ROE 3.77%
Debt/Equity 0.43
Chartmill High Growth Momentum
EPS Q2Q%-3.28%
Sales Q2Q%4.1%
EPS 1Y (TTM)5.62%
Revenue 1Y (TTM)3.33%

RVTY Forecast & Estimates

26 analysts have analysed RVTY and the average price target is 121.75 USD. This implies a price increase of 23.12% is expected in the next year compared to the current price of 98.89.

For the next year, analysts expect an EPS growth of 1.21% and a revenue growth 3.49% for RVTY


Analysts
Analysts77.69
Price Target121.75 (23.12%)
EPS Next Y1.21%
Revenue Next Year3.49%

RVTY Ownership

Ownership
Inst Owners100.5%
Ins Owners0.3%
Short Float %6.05%
Short Ratio5.16